Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways
Jiaojiao Yu, Lijing Zhang, Jun Peng, et al.
Biochemical Pharmacology (2021) Vol. 195, pp. 114864-114864
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Advances and challenges in the treatment of lung cancer
Yuting Li, Bingshuo Yan, Shiming He
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115891-115891
Open Access | Times Cited: 95
CETSA and thermal proteome profiling strategies for target identification and drug discovery of natural products
Yanbei Tu, Lihua Tan, Hongxun Tao, et al.
Phytomedicine (2023) Vol. 116, pp. 154862-154862
Closed Access | Times Cited: 42
Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges
Yuchu Xiang, Xudong Liu, Yifan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 14
The Art of Finding the Right Drug Target: Emerging Methods and Strategies
Zi-Chang Jia, Xue Yang, Yikun Wu, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 896-914
Open Access | Times Cited: 8
Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery
Tanya Biswas, Ravi K. Mittal, Vikram Sharma, et al.
Medicinal Chemistry (2024) Vol. 20, Iss. 4, pp. 369-384
Closed Access | Times Cited: 6
Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention
Lü Jian, Feng Ding, Yongjie Sun, et al.
Cellular Signalling (2025), pp. 111608-111608
Closed Access
Beta-sitosterol regulates PTGS1 to inhibit gastric cancer cell proliferation and angiogenesis
Jindao Wang, Ming-Hui Zhou, Qiuli Zhou, et al.
Prostaglandins & Other Lipid Mediators (2025), pp. 106964-106964
Closed Access
Multiple post-translational modifications ensure EGFR functionality: Potential therapeutic targets to overcome its drug-resistance mutations
Qiangqiang He, Meiyu Qu, Hangyang Bao, et al.
Cytokine & Growth Factor Reviews (2023) Vol. 70, pp. 41-53
Closed Access | Times Cited: 16
Furoquinoline Alkaloids: Insights into Chemistry, Occurrence, and Biological Properties
Agnieszka Szewczyk, Filip Pęczek
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12811-12811
Open Access | Times Cited: 14
Recent advances in molecular targeted therapy of lung cancer: Possible application in translation medicine.
Elnaz Salmani-Javan, Mahdi Farhoudi Sefidan Jadid, Nosratollah Zarghami
PubMed (2024) Vol. 27, Iss. 2, pp. 122-133
Closed Access | Times Cited: 4
Dictamnine suppresses the development of pear ring rot induced by Botryosphaeria dothidea infection by disrupting the chitin biosynthesis
Minxuan Yuan, Xiao‐Gui Liang, Duantao Cao, et al.
Pesticide Biochemistry and Physiology (2023) Vol. 195, pp. 105534-105534
Closed Access | Times Cited: 12
Insulin resistance in NSCLC: unraveling the link between development, diagnosis, and treatment
Shizhang Zhan, Liu Wang, Wenping Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
Static Binding and Dynamic Transporting‐Based Design of Specific Ring‐Chain‐Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product
Zhiyang Zhang, Jianwu Lv, Yu Wang, et al.
Chemistry - A European Journal (2023) Vol. 29, Iss. 25
Closed Access | Times Cited: 10
2,3,5,6-Tetramethylpyrazine Targets Epithelial-Mesenchymal Transition by Abrogating Manganese Superoxide Dismutase Expression and TGFβ-Driven Signaling Cascades in Colon Cancer Cells
Young Yun Jung, Chakrabhavi Dhananjaya Mohan, Huiyan Eng, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 891-891
Open Access | Times Cited: 15
Functional role of MicroRNA/PI3K/AKT axis in osteosarcoma
Y Xiang, Yingxin Yang, Jia Liu, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 9
Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects
Daoan Cheng, Kele Ge, Xue Yao, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Single‐cell RNA sequencing reveals the mechanism of PI3K/AKT/mTOR signaling pathway activation in lung adenocarcinoma by KRAS mutation
Long Xu, Renquan Ding, Shuxi Song, et al.
The Journal of Gene Medicine (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 2
Dysregulated expression of microRNA involved in resistance to osimertinib in EGFR mutant non-small cell lung cancer cells
Dianbao Zhang, Yukun Yang, Yixin Kang, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 4, pp. 1978-1993
Open Access | Times Cited: 7
The prospect of combination therapies with the third-generation EGFR-TKIs to overcome the resistance in NSCLC
Shiyu Li, Shuangli Zhu, Hongqu Wei, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 156, pp. 113959-113959
Closed Access | Times Cited: 12
Pd/Cu catalyzed carbonylation of α-aminoaryl-tethered alkylidenecyclopropanes: synthesis of furoquinoline derivatives
Lin Li, Hui-Hui Zeng, You‐Ya Zhang, et al.
Organic Chemistry Frontiers (2022) Vol. 9, Iss. 24, pp. 6802-6807
Closed Access | Times Cited: 10
Antitumor activity of dictamnine against colorectal cancer through induction of ferroptosis and inhibition of M2 macrophage polarization via the MAPK signaling
Xingsheng Zuo, Haiguan Lin, Zhiyu Song, et al.
Archives of Biochemistry and Biophysics (2024) Vol. 758, pp. 110051-110051
Closed Access | Times Cited: 1
Alkaloid-Based Modulators of the PI3K/Akt/mTOR Pathway for Cancer Therapy: Understandings from Pharmacological Point of View
Fatima Zohra Mokhfi, Md. Al Amin, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2024) Vol. 402, pp. 111218-111218
Closed Access | Times Cited: 1
Tetrahydroquinoline: An Efficient Scaffold As mTOR Inhibitor for the Treatment of Lung Cancer
Udit Chaube, Rajdeep Dey, Suman Shaw, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 23, pp. 1789-1809
Closed Access | Times Cited: 9
Cancer chemoprevention with PV-1, a novel Prunella vulgaris-containing herbal mixture that remodels the tumor immune microenvironment in mice
Qi Zhang, Xu Chen, Katie Palen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
RFC2 promotes aerobic glycolysis and progression of colorectal cancer
Fuchen Lou, Mingbao Zhang
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top